Hematological system Flashcards
Bone marrow biopsy
coring out an area of bone marrow with a large-bore needle ; iliac crest ( sternum ) ; anesthesia or sedation ; apply pressure; observe ! 24 hrs - bleeding & infection; analgesic ( aspirin free) ; ice packs
Bence-Jones Protein
urine test; single sample or 24 hrs urine collection; positive 75 % pts with multiple myeloma + neoplasms affecting bone, blood, lymphatic system
Schilling’s test
to determine vitamin B12 absorption ; pernicious anemia = Stage 1 abnormal + stage 2 normal ; Malabsorption = both stages abnormal ; NPO ( 8-12) - oral B12 - 1-2 hrs later IM B12 - Eat and drink + 24 hrs urine collection
RBC count - Men & Women
M 4.7-6.1
W 4.2-5.4
Reticulocyte count
immature RBCs - reflects bone marrow activity
Hemoglobin - M & W
M 13.5-18 gm/dL
W 12-16 gm/dL
gas carrying capacity of RBCs ; below 6 gm/dL - severe
Hematocrit - M & W - RBCs as %
M 40-54 %
W - 38-47 %
WBC differential
5000 - 10000 mm3
Platelet count - thrombocytes
150000-400000
Coombs test - Direct vs Indirect
- Direct - used to detect antibodies that are stuck to the surface of red blood cells. These antibodies sometimes destroy red blood cells and cause anemia.
- Indirect - looks for free-flowing antibodies against certain red blood cells. It is is most often done to determine if you may have a reaction to a blood transfusion.
Bilirubin
increased with hemolytic problems; reflects liver function
PT
11-12.5 seconds
aPTT
30-40 seconds ; therapeutic 1.5-2.5 x control
Therapeutic INR
2-3.5
Disseminated Intravascular Coagulation - DIC
complication of another disorder : diffuse clotting + hemorrhage
s/s: ecchymosis, petechiae, purpura fulminans
Triggers for DIC
- Massive trauma
- Shock
- Sepsis or infection - gram negative; meningococcal
- Acute promyelocytic leukemia
- Metastatic cancers
- Obstetrical emergency
- Transfusion reaction
- Severe liver disease
DIC - pathophysiology
Underlying disorder - Interleukins and TNF ( tumor necrosis factors) - Systemic activation of coagulation -
- widespread intravascular fibrin deposition - thrombosis and organ failure
- consumption of platelets and clotting factors - severe bleeding
DIC - complications
- Renal failure
- Gangrene
- PE
- Hemorrhage
- CVA
- ARDS
- MODS
- Death
DIC - elevated labs
- PT/INR
- aPTT
- FSP ( fibrin split products ); FDP ( fibrin degradation products); D-dimer
DIC - decreased labs
- Platelet count
2. Fibrinogen level
Fibrinogen
is a protein produced by the liver. This protein helps stop bleeding by helping blood clots to form
DIC: TX
- Supportive care
- Blood products - platelets, fresh frozen plasma, cryoprecipitate ( replace fibrinogen)
- Heparin therapy (prevent more clots)
- Epsilon-aminocaproic acid ( inhibitor of fibrinolysis) or Activated protein C
Activated protein C
enzyme that helps prevent inappropriate clot formation; its activated when it binds to healthy endothelial cells - injured ( sepsis …) - cannot activate protein C - clots are formed
Leukemia - acute or chronic - myelogenous or lymphocytic
- Increase in immature non-functional WBCs - blasts
- Decrease in mature, healthy WBCs, RBCs and platelets
- stem cells - bone marrow problem
Philadelphia chromosome - chromosome analysis
- major feature - CML
2. hallmark ALL
Leukemia S/s
- early - none
- Fever, generalized bone pain
- Infections, weigh loss + anorexia
- S/s of anemia and thrombocytopenia
“7 plus 3” - cytosine arabinoside + daunorubicin
Tx acute leukemia - severe bone marrow suppression - induction therapy
TX acute leukemia -
SE - Infection + Bleeding
- Induction
2, Consolidation - cure - Maintenance - 2-5 years
Imatinib mesylate (Gleevec) - SE
CML+ Philadelphia chromosome
SE - N/V - take with meal + large glass of water
No grapefruit juice
Muscle cramps - may need Ca
Increase risk for bleeding, diarrhea, rash, fluid retention
Hematopoietic Stem Cell Transplantation - Bone marrow transplant - Indications
- for leukemia patients in remission after induction therapy that have closed matched donor
- lymphoma
- multiple myeloma
- aplastic anemia
- sickle cell disease and many solid tumors
Human leukocyte antigen - HLA
matched stem cells may be obtained from a family member or unrelated donor ( 1 in 5000 ).
Bone marrow transplant and leukemia
Additional chemo with or without whole body radiation is given ( lethal to the bone marrow ) - new cell are given - go to the marrow - if function properly - produce permanent cure
!!! Graft vs Host - immunossupresant for the rest of the life - graft attacks host ; 15 % die
Leukemia - Risk
- any age
- genetic
- chemical agents
- hx of chemo
- radiation exposure
Chemotherapeutic agents - SE
- hair loss
- N/V
- toxicities and interfere with growth of many tissues
- myelosuppression
- birth defects and potential sterility
Chemotherapy - action
destroy the cells that are rapidly dividing ( malignant) ; any other cells that are reproducing at that time - destroyed as well.
Antineoplastic agents
- Alkylating - interfere with mitosis and cell division usually at any stage of the growth cycle
- Cytotoxic - “cin-mycin” - antibiotic neoplastics - interfere with DNA and or RNA and protein synthesis
- Antimetabolites - interfere with biosynthesis - used for solid tumors
Lymphoma
- Solid tumor
- Abnormal overgrowth of lymphocytes
- Lymph nodes + spleen problem
Reed-Sternberg cells
Hodgkin’s lymphoma
Hodgkin’s lymphoma - Risk
- young adults and those over age 50 - men
- genetic
- viral - Epstain-Barr virus
- occupational toxins